213 related articles for article (PubMed ID: 24880585)
1. Experimental and Monte Carlo dosimetric characterization of a 1 cm (103)Pd brachytherapy source.
Reed JL; Rivard MJ; Micka JA; Culberson WS; DeWerd LA
Brachytherapy; 2014; 13(6):657-67. PubMed ID: 24880585
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
3. 103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design.
Rivard MJ; Reed JL; DeWerd LA
Med Phys; 2014 Jan; 41(1):011716. PubMed ID: 24387508
[TBL] [Abstract][Full Text] [Related]
4. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Meigooni AS; Sowards K; Soldano M
Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
[TBL] [Abstract][Full Text] [Related]
6. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
Kennedy RM; Davis SD; Micka JA; DeWerd LA
Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
[TBL] [Abstract][Full Text] [Related]
7. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
Sadeghi M; Hosseini SH; Raisali G
Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
[TBL] [Abstract][Full Text] [Related]
8. Air-kerma strength determination of a new directional (103)Pd source.
Aima M; Reed JL; DeWerd LA; Culberson WS
Med Phys; 2015 Dec; 42(12):7144-52. PubMed ID: 26632069
[TBL] [Abstract][Full Text] [Related]
9. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
Monroe JI; Williamson JF
Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
[TBL] [Abstract][Full Text] [Related]
12. Thermoluminescent and Monte Carlo dosimetry of a new 170Tm brachytherapy source.
Nazari S; Sadeghi M; Shirvani-Arani S; Bahrami-Samani A; Saidi P
Phys Med; 2014 Mar; 30(2):178-83. PubMed ID: 23764298
[TBL] [Abstract][Full Text] [Related]
13. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
15. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
Rodriguez M; Rogers DW
Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
[TBL] [Abstract][Full Text] [Related]
17. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
Nath R; Yue N; Roa E
Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
[TBL] [Abstract][Full Text] [Related]
20. Theoretical and experimental determination of dosimetric characteristics for brachyseed Pd-103, model Pd-1, source.
Meigooni AS; Zhang H; Perry C; Dini SA; Koona RA
Appl Radiat Isot; 2003 May; 58(5):533-41. PubMed ID: 12735969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
